The laboratories of Maria A. Croyle RPh., PhD.
The University of Texas at Austin's College of Pharmacy
Dr Maria A. Croyle RPh., PhD is a Professor of Pharmaceutics at The University of Texas at Austin College of Pharmacy where she has lead a busy research lab in pursuit of a single-dose, long-lasting Adenovirus-based Ebola vaccine, as well as studies in drug metabolism, novel vaccine formulations and other viral vectors.
Her students have come from all over the world to be challenged by the plethora of skill sets represented in such an innovative research environment.
Dr Croyle presents: “Biosafety Considerations in the Development of an Ebola Vaccine:
Containment, Animal Transport, and More!”
Journal: Molecular Pharmaceutics
Manuscript ID: mp-2014-00646d.R1
Author(s): Choi, Jin; Jonsson-Schmunk, Kristina; Qiu, Xiangguo; Shedlock, Devon; Strong, Jim; Xu, Jason; Michie, Kelly; Audet, Jonathan; Fernando, Lisa; Myers, Mark; Weiner, David; Bajrovic, Irnela; Tran, Lilian; Wong, Gary; Bello, Alexander; Kobinger, Gary; Schafer, Stephen; Croyle, Maria
Dr Croyle, Kristina, Mark, Jason, Lilian and Irnela travel to San Diego for the annual meeting of the American Association of Pharmaceutical Scientists. Dr Croyle will release details about our latest publication detailing the successful inhalation vaccination of non-human primates against Ebola virus.
Dr Croyle provides a retrospective review of use of animal models, including challenges faced along the way, what was and is important for quality and output of biomedical research facilitated by animal and veterinary care, with respect to developing a viable
vaccine for Ebola.
Talk title: "Development of an Effective Vaccine Against Ebola Under the
U.S. FDA Animal Rule: A Multi-Disciplinary, International Effort".
Dr Croyle was invited by Chairman Charles Schwertner to testify before the Texas State Senate and provide information on the development of vaccines for Ebola and timelines for vaccine development. In a live television broadcast, she was asked to comment on the development of small molecule therapies for the treatment and prevention of Ebola.
Link to archived video.